Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging

Annals of Neurology

Volumn 36, Issue 2, 1994, Pages 157-165

  Husted, C A ^a,b   Goodin, D S ^a,b   Hugg, J W ^a,c   Maudsley, A A ^a,b   Tsuruda, J S ^a,d   de Bie, S H ^a,e   Fein, G ^a,b   Matson, G B ^a,b   Weiner, M W ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PHOSPHOLIPID DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; FEMALE; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; PHOSPHOCREATINE; PHOSPHORUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028147810     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360207     Document Type: Article

References (47)

1. Immunocytochemical localization of N ‐acetyl‐aspartate with monoclonal antibodies
2. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease
3. Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis
4. Proton magnetic resonance spectroscopy and multiple sclerosis
5. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
6. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
7. Human brain proton localized NMR spectroscopy in multiple sclerosis
8. H‐1 spectroscopic imaging depicts focal metabolic changes in multiple sclerosis
9. 31P MR spectroscopic imaging (MRSI) of multiple sclerosis
10. MR proton spectroscopy in multiple sclerosis
11. 31P NMR detection of mobile dog brain phospholipids
12. Phospholipid bilayer contribution to 31P NMR spectra in vivo
13. 31P‐NMR study of brain phospholipid structures in vivo
14. Chemical pathology of diseases involving myelin
15. 31P NMR spectroscopy in patients with multiple sclerosis (MS): a correlation with clinical data
16. In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis
17. Biochemical changes within a multiple sclerosis plaque in vivo
18. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders
19. Spin‐lattice relaxation (T1) times of cerebral white matter in multiple sclerosis
20. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis
21. Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease
22. Changes within the “normal” cerebral white matter of multiple sclerosis patients during acute attacks and during high‐dose cortisone therapy assessed by means of quantitative MRI
23. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis
24. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging
25. Use of diffusion weighted magnetic resonance imaging in multiple sclerosis
26. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis
27. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
28. A neurologic rating scale (NRS) for use in multiple sclerosis
29. A sharper Bonferroni procedure for multiple tests of significance
30. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
31. Distribution of glial fibrillary acidic protein in gliosed human white matter
32. A thiol proteinase highly elevated in and around the plaques of multiple sclerosis
33. Lipid chemistry of the brain in demyelinating diseases
34. Brain lipids in multiple sclerosis and other diseases
35. The glycerophospholipid content of the white matter of normal and MS brains
36. 2′,3′‐Cyclic nucleotide 3′‐phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains
37. Alteration of lipid‐phase behavior in multiple sclerosis myelin revealed by wide‐angle x‐ray diffraction
38. White matter proteins in multiple sclerosis
39. Is the myelin membrane abnormal in multiple sclerosis?
40. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations
41. Studies on the pathogenesis of multiple sclerosis
42. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis
43. Multiple sclerosis: distribution of T cells, T cell subsets and Ia‐positive macrophages in lesions of different ages
44. Fos RNA accumulation in multiple sclerosis white matter tissue
45. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue